1. Air Pollution and Atopic Dermatitis, from Molecular Mechanisms to Population-Level Evidence: A Review. Int J Environ Res Public Health. 2023 Jan 31; 20(3).Fadadu RP, Abuabara K, Balmes JR, Hanifin JM, Wei ML.  PMID: 36767891; PMCID: PMC9916398.

3. Association of Wildfire Air Pollution With Clinic Visits for Psoriasis. JAMA Netw Open. 2023 Jan 03; 6(1):e2251553.Fadadu RP, Green M, Grimes B, Jewell NP, Seth D, Vargo J, Wei ML.  PMID: 36637821.

4. Learning Melanocytic Cell Masks from Adjacent Stained Tissue. arXiv. 2022.Tada M, Wei ML, Keiser MJ. View Publication.

5. Association of Exposure to Wildfire Air Pollution With Exacerbations of Atopic Dermatitis and Itch Among Older Adults. JAMA Netw Open. 2022 10 03; 5(10):e2238594.Fadadu RP, Green M, Jewell NP, Grimes B, Vargo J, Wei ML.  PMID: 36287569; PMCID: PMC9606843.

6. Ultraviolet A radiation exposure and melanoma: a review. Melanoma Res. 2022 12 01; 32(6):405-410.Fadadu RP, Wei ML.  PMID: 36125897.

7. Associations between wildfire air pollution and online search interest for skin diseases and symptoms. JAAD Int. 2022 Sep; 8:128-130.Fadadu RP, Chen JY, Wei ML.  PMID: 35875399; PMCID: PMC9305359.

8. Disparities in access for melanoma screening by region, specialty, and insurance: A cross-sectional audit study. JAAD Int. 2022 Jun; 7:78-85.Cortez JL, Fadadu RP, Konda S, Grimes B, Wei ML.  PMID: 35373156; PMCID: PMC8968658.

9. A rare case of axillary keratoacanthoma arising in hidradenitis suppurativa. JAAD Case Rep. 2022 Mar; 21:49-51.Chen JY, Keiser E, LeBoit P, Yeh I, Wei ML.  PMID: 35146101; PMCID: PMC8818802.

10. BRAFV600E induces reversible mitotic arrest in human melanocytes via microrna-mediated suppression of AURKB. Elife. 2021 11 23; 10.McNeal AS, Belote RL, Zeng H, Urquijo M, Barker K, Torres R, Curtin M, Shain AH, Andtbacka RH, Holmen S, Lum DH, McCalmont TH, VanBrocklin MW, Grossman D, Wei ML, Lang UE, Judson-Torres RL.  PMID: 34812139; PMCID: PMC8610417.

11. A cross-sectional analysis of Medicaid acceptance among US dermatology residency training programs. J Am Acad Dermatol. 2022 02; 86(2):453-455.Williams JC, Maxey AE, Wei ML, Amerson EH.  PMID: 34597750.

12. Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review. Lancet Digit Health. 2021 09; 3(9):e599-e611.Young AT, Amara D, Bhattacharya A, Wei ML.  PMID: 34446266.

13. Association of Wildfire Air Pollution and Health Care Use for Atopic Dermatitis and Itch. JAMA Dermatol. 2021 Jun 01; 157(6):658-666.Fadadu RP, Grimes B, Jewell NP, Vargo J, Young AT, Abuabara K, Balmes JR, Wei ML.  PMID: 33881450; PMCID: PMC8060890.

14. Robust semantic interpretability: Revisiting concept activation vectors. arXiv. 2021.Pfau J, Young AT, Wei, J, Wei ML, Keiser MJ. View Publication.

15. Dermoscopy Proficiency Expectations for US Dermatology Resident Physicians: Results of a Modified Delphi Survey of Pigmented Lesion Experts. JAMA Dermatol. 2021 02 01; 157(2):189-197.Fried LJ, Tan A, Berry EG, Braun RP, Curiel-Lewandrowski C, Curtis J, Ferris LK, Hartman RI, Jaimes N, Kawaoka JC, Kim CC, Lallas A, Leachman SA, Levin A, Lucey P, Marchetti MA, Marghoob AA, Miller D, Nelson KC, Prodanovic E, Seiverling EV, Swetter SM, Savory SA, Usatine RP, Wei ML, Polsky D, Stein JA, Liebman TN.  PMID: 33404623; PMCID: PMC7788510.

16. Stress testing reveals gaps in clinic readiness of image-based diagnostic artificial intelligence models. NPJ Digit Med. 2021 Jan 21; 4(1):10.Young AT, Fernandez K, Pfau J, Reddy R, Cao NA, von Franque MY, Johal A, Wu BV, Wu RR, Chen JY, Fadadu RP, Vasquez JA, Tam A, Keiser MJ, Wei ML.  PMID: 33479460; PMCID: PMC7820258.

17. Prognostic Gene Expression Profiling in Cutaneous Melanoma: Identifying the Knowledge Gaps and Assessing the Clinical Benefit. JAMA Dermatol. 2020 09 01; 156(9):1004-1011.Grossman D, Okwundu N, Bartlett EK, Marchetti MA, Othus M, Coit DG, Hartman RI, Leachman SA, Berry EG, Korde L, Lee SJ, Bar-Eli M, Berwick M, Bowles T, Buchbinder EI, Burton EM, Chu EY, Curiel-Lewandrowski C, Curtis JA, Daud A, Deacon DC, Ferris LK, Gershenwald JE, Grossmann KF, Hu-Lieskovan S, Hyngstrom J, Jeter JM, Judson-Torres RL, Kendra KL, Kim CC, Kirkwood JM, Lawson DH, Leming PD, Long GV, Marghoob AA, Mehnert JM, Ming ME, Nelson KC, Polsky D, Scolyer RA, Smith EA, Sondak VK, Stark MS, Stein JA, Thompson JA, Thompson JF, Venna SS, Wei ML, Swetter SM.  PMID: 32725204; PMCID: PMC8275355.

18. The impact of demographics, socioeconomics, and health care access on melanoma outcomes. J Am Acad Dermatol. 2021 Jun; 84(6):1677-1683.Cortez JL, Vasquez J, Wei ML.  PMID: 32783908.

19. The role of technology in melanoma screening and diagnosis. Pigment Cell Melanoma Res. 2021 03; 34(2):288-300.Young AT, Vora NB, Cortez J, Tam A, Yeniay Y, Afifi L, Yan D, Nosrati A, Wong A, Johal A, Wei ML.  PMID: 32558281.

20. Reply to Problematic methodology in a systematic review and meta-analysis of DecisionDx-Melanoma. J Am Acad Dermatol. 2020 11; 83(5):e359-e360.Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML.  PMID: 32526325.

21. Artificial Intelligence in Dermatology: A Primer. J Invest Dermatol. 2020 08; 140(8):1504-1512.Young AT, Xiong M, Pfau J, Keiser MJ, Wei ML.  PMID: 32229141.

22. Molecular risk prediction in cutaneous melanoma: A meta-analysis of the 31-gene expression profile prognostic test in 1,479 patients. J Am Acad Dermatol. 2020 Sep; 83(3):745-753.Greenhaw BN, Covington KR, Kurley SJ, Yeniay Y, Cao NA, Plasseraud KM, Cook RW, Hsueh EC, Gastman BR, Wei ML.  PMID: 32229276.

23. Global saliency: Aggregating saliency maps to assess dataset artefact bias. arXiv. 2019.Pfau J, Young AT, Wei ML, Keiser MJ. View Publication.

24. MicroRNA Ratios Distinguish Melanomas from Nevi. J Invest Dermatol. 2020 01; 140(1):164-173.e7.Torres R, Lang UE, Hejna M, Shelton SJ, Joseph NM, Shain AH, Yeh I, Wei ML, Oldham MC, Bastian BC, Judson-Torres RL.  PMID: 31580842; PMCID: PMC6926155.

25. Artificial Intelligence in Teledermatology. Curr Derm Rep. 2019.Xiong M, Pfau J, Young AT, Wei ML. View Publication.

26. Suction Blisters. JAMA Dermatol. 2019 Feb 01; 155(2):237.Yu WY, Wei ML.  PMID: 30540360.

27. Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials. Cancer. 2019 01 01; 125(1):18-44.Jeter JM, Bowles TL, Curiel-Lewandrowski C, Swetter SM, Filipp FV, Abdel-Malek ZA, Geskin LJ, Brewer JD, Arbiser JL, Gershenwald JE, Chu EY, Kirkwood JM, Box NF, Funchain P, Fisher DE, Kendra KL, Marghoob AA, Chen SC, Ming ME, Albertini MR, Vetto JT, Margolin KA, Pagoto SL, Hay JL, Grossman D, Ellis DL, Kashani-Sabet M, Mangold AR, Markovic SN, Meyskens FL, Nelson KC, Powers JG, Robinson JK, Sahni D, Sekulic A, Sondak VK, Wei ML, Zager JS, Dellavalle RP, Thompson JA, Weinstock MA, Leachman SA, Cassidy PB.  PMID: 30281145; PMCID: PMC6860362.

28. Outcomes and Risk Factors in Patients with Multiple Primary Melanomas. J Invest Dermatol. 2019 01; 139(1):195-201.Nosrati A, Yu WY, McGuire J, Griffin A, de Souza JR, Singh R, Linos E, Chren MM, Grimes B, Jewell NP, Wei ML.  PMID: 30031745; PMCID: PMC9191767.

29. Precision Diagnosis Of Melanoma And Other Skin Lesions From Digital Images. AMIA Jt Summits Transl Sci Proc. 2017; 2017:220-226.Bhattacharya A, Young A, Wong A, Stalling S, Wei M, Hadley D.  PMID: 28815132; PMCID: PMC5543387.

30. Outcomes of Melanoma In Situ Treated With Mohs Micrographic Surgery Compared With Wide Local Excision. JAMA Dermatol. 2017 05 01; 153(5):436-441.Nosrati A, Berliner JG, Goel S, McGuire J, Morhenn V, de Souza JR, Yeniay Y, Singh R, Lee K, Nakamura M, Wu RR, Griffin A, Grimes B, Linos E, Chren MM, Grekin R, Wei ML.  PMID: 28241261; PMCID: PMC5817486.

31. The role of IL-17 in vitiligo: A review. Autoimmun Rev. 2016 Apr; 15(4):397-404.Singh RK, Lee KM, Vujkovic-Cvijin I, Ucmak D, Farahnik B, Abrouk M, Nakamura M, Zhu TH, Bhutani T, Wei M, Liao W.  PMID: 26804758; PMCID: PMC4769658.

32. Patients' preferences for biopsy result notification in an era of electronic messaging methods. JAMA Dermatol. 2015 May; 151(5):513-21.Choudhry A, Hong J, Chong K, Jiang B, Hartman R, Chu E, Nelson K, Wei ML, Nguyen T.  PMID: 25831475.

33. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma. Melanoma Res. 2015 Apr; 25(2):138-48.Yue L, Huang ZM, Fong S, Leong S, Jakowatz JG, Charruyer-Reinwald A, Wei M, Ghadially R.  PMID: 25643237.

34. Sex disparities in melanoma outcomes: the role of biology. Arch Biochem Biophys. 2014 Dec 01; 563:42-50.Nosrati A, Wei ML.  PMID: 25057772.

35. Basis for enhanced barrier function of pigmented skin. J Invest Dermatol. 2014 Sep; 134(9):2399-2407.Man MQ, Lin TK, Santiago JL, Celli A, Zhong L, Huang ZM, Roelandt T, Hupe M, Sundberg JP, Silva KA, Crumrine D, Martin-Ezquerra G, Trullas C, Sun R, Wakefield JS, Wei ML, Feingold KR, Mauro TM, Elias PM.  PMID: 24732399; PMCID: PMC4134407.

36. Targeting protein-trafficking pathways alters melanoma treatment sensitivity. Proc Natl Acad Sci U S A. 2012 Jan 10; 109(2):553-8.Huang ZM, Chinen M, Chang PJ, Xie T, Zhong L, Demetriou S, Patel MP, Scherzer R, Sviderskaya EV, Bennett DC, Millhauser GL, Oh DH, Cleaver JE, Wei ML.  PMID: 22203954; PMCID: PMC3258646.

37. The MADS box transcription factor MEF2C regulates melanocyte development and is a direct transcriptional target and partner of SOX10. Development. 2011 Jun; 138(12):2555-65.Agarwal P, Verzi MP, Nguyen T, Hu J, Ehlers ML, McCulley DJ, Xu SM, Dodou E, Anderson JP, Wei ML, Black BL.  PMID: 21610032; PMCID: PMC3100711.

38. Multidrug resistance decreases with mutations of melanosomal regulatory genes. Cancer Res. 2009 Feb 01; 69(3):992-9.Xie T, Nguyen T, Hupe M, Wei ML.  PMID: 19155314.

39. Hermansky-Pudlak HPS1/pale ear gene regulates epidermal and dermal melanocyte development. J Invest Dermatol. 2007 Feb; 127(2):421-8.Nguyen T, Wei ML.  PMID: 17068483.

40. Hermansky-Pudlak syndrome: a disease of protein trafficking and organelle function. Pigment Cell Res. 2006 Feb; 19(1):19-42.Wei ML.  PMID: 16420244.

41. Characterization of melanosomes in murine Hermansky-Pudlak syndrome: mechanisms of hypopigmentation. J Invest Dermatol. 2004 Feb; 122(2):452-60.Nguyen T, Wei ML.  PMID: 15009730.

42. Melanosome morphologies in murine models of hermansky-pudlak syndrome reflect blocks in organelle development. J Invest Dermatol. 2002 Nov; 119(5):1156-64.Nguyen T, Novak EK, Kermani M, Fluhr J, Peters LL, Swank RT, Wei ML.  PMID: 12445206.

43. Class I-like CD1A-C do not protect target cells from NK-mediated cytolysis. Cell Immunol. 1996 Jan 10; 167(1):154-6.Storkus WJ, Wei M, Cresswell P, Dawson JR.  PMID: 8548840.

44. Intracellular transport of class I MHC molecules in antigen processing mutant cell lines. J Immunol. 1993 Oct 01; 151(7):3407-19.Anderson KS, Alexander J, Wei M, Cresswell P.  PMID: 8376783.

45. HLA-A2 molecules in an antigen-processing mutant cell contain signal sequence-derived peptides. Nature. 1992 Apr 02; 356(6368):443-6.Wei ML, Cresswell P.  PMID: 1557127.

46. Transport and expression of class I MHC glycoproteins in an antigen-processing mutant cell line. Cold Spring Harb Symp Quant Biol. 1992; 57:571-7.Click EM, Anderson KS, Androlewicz MJ, Wei ML, Cresswell P.  PMID: 1339695.

47. Chlorination of taurine by human neutrophils. Evidence for hypochlorous acid generation. J Clin Invest. 1982 Sep; 70(3):598-607.Weiss SJ, Klein R, Slivka A, Wei M.  PMID: 6286728; PMCID: PMC370261.